DNL-126

N/A

Report date: 2025/03/18 15:02:41

Base Information

Drug NameDNL-126
Drug Alias NameRecombinant sulphoglucosamine sulphohydrolaseETV:N-sulphoglucosamine sulphohydrolaseDNL-126ETV:SGSHETV-SGSH
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionN-sulphoglucosamine sulphohydrolase replacements
TargetsN-sulphoglucosamine sulphohydrolase
Therapy Area/IndicationsMucopolysaccharidosis III
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDenali Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDenali Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis III
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A